Business Wire

NC-PERCONA

23.5.2023 15:01:36 CEST | Business Wire | Press release

Share
The Percona 2023 State of Open Source Database Survey Reveals Reluctance Among Businesses to Alter Database Strategies in the Face of Economic Uncertainty

Percona, a leader in enterprise-grade open source database software, support, and services, today announced the initial findings of its State of Open Source Database Survey report for 2023 during its annual Percona Live conference. According to the survey of nearly 300 database professionals working in companies ranging in size from small-to-medium-sized business to large enterprise, the database market is currently in a period of stasis around database deployments and changes, most likely due to economic uncertainty and post-COVID-19 recovery. The research indicates that most organizations are not planning to make significant alterations to their database strategies over the course of the next three years.

Alongside this broader revelation, the study sheds light on a number of database operations concerns for organizations, including challenges around developer agility, and significant factors driving the choice between deploying open source or proprietary databases.

Findings in the 2023 State of Open Source Database Survey include:

  • More respondents indicate their organizations are doing well with a host of database operations metrics than they are with meeting developer needs:
    • More than 70 percent of respondents say they are doing somewhat or extremely well with database reliability, performance, security, privacy, scalability and backup reliability and integrity.
    • Conversely, meeting the needs of developers placed last on the list of 14 operational metrics collected, with only 55 percent of respondents saying they are doing well in developer agility.
  • Comparing large enterprises and small-to-medium businesses, the research shows that bigger companies tend to have more tools and automation deployed to help their teams:
    • Large enterprises are much more likely to use database monitoring and management solutions, with 93 percent of organizations having such tools in place. Conversely, only 57 percent of small businesses have database monitoring and management solutions deployed.
    • Small companies are much more likely to use on-premises and cloud services to host their databases (49 percent) compared to 26 percent of large enterprises. Large enterprises are also much more likely to use DBaaS offerings (32 percent of deployments).

“Our report indicates that database deployment strategies are expected to remain static for the next few years, with levels of usage remaining consistent across all categories of relational and non-relational databases,” said Joe Brockmeier, Head of Community at Percona. “We’re seeing caution around making significant changes to deployments following the large-scale digital transformation undertaken during the pandemic and the uncertain economic climate the world is facing in 2023. Teams want to improve how they manage, monitor and run those deployments rather than implementing more changes.”

Further findings include:

  • When asked about what drove their choice to use open source databases, respondents most often cited cost reductions (83 percent rated as somewhat or extremely significant) and developer choice (81 percent), followed by faster deployment (75 percent) and then security and more control (73 percent each).
  • For respondents that implemented proprietary databases, the findings are very different – the biggest factors are greater stability (68 percent), more security (63 percent) and regulatory compliance (61).
  • Developer choice was not in the top ten reasons to deploy proprietary databases, pointing to a much larger preference for open source solutions for the developer community.
  • The majority of respondents say their organizations rely on both relational and non-relational databases – 99 percent of respondents run at least one relational database, and 86 percent run at least one non-relational database.
    • MySQL is the most popular relational database, followed by PostgreSQL and Oracle Server at 57, 48 and 47 percent respectively.
    • MongoDB is the most commonly deployed non-relational database, followed by Couchbase and Redis.

“Developers prefer open source software where they have choice and autonomy over how they can architect and build their applications. The flexibility and performance benefits aside, open source also helps companies save on costs compared to running proprietary databases, which can’t be ignored in today’s economy. However, companies can still improve how they run and manage those installations, and that is where Percona can really help,” said Ann Schlemmer, CEO at Percona.

Speakers at this year’s Percona Live will discuss these and other findings from the 2023 survey. Percona Live is sponsored by a range of companies in the data and database markets, including Microsoft, AWS, Oracle, PlanetScale, FerretDB, Datavail, OtterTune, benchAnt, Victoria Metrics, Civo, and DBeaver.

If you would like to be notified when the full report from this survey is made available, please send an email with the request to: databasesurvey@percona.com

About Percona

Percona is widely recognized as a world-class open source database software, support, and services company. The organization is dedicated to helping businesses make databases and applications run better through a unique combination of expertise and open source software. Percona works with numerous global brands across many industries, creating a unified experience to monitor, manage, secure, and optimize database environments on any infrastructure.

Percona equips organizations with the freedom to choose, the freedom to create, and the freedom to make a difference - helping them scale and innovate with speed as they grow. For more information, visit www.percona.com.

Databases run better with Percona.

Percona® is a registered trademark of Percona LLC. All other registered and unregistered trademarks in this document are the sole property of their respective owners.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230523005396/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release

Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release

About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release

Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break

Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release

Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye